Skip to content
Pharma Observatory a Scientist.com platform

Organization (Industry)

Pharming Group N.V.

ClinicalTrials.gov lists Pharming Group N.V. as lead sponsor of 22 trials, counting the companies grouped under it.

NL Manufacturer CIK 0001828316
Email me this page as a PDF

Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Companies grouped under this page Companies grouped under this page 1 Disease areas Disease areas 19 Journals published in Journals published in 48 Financing and grant events Financing and grant events 1 Organization relationships Organization relationships 2 Latest dated events Latest dated events 27 Companies grouped under this page Companies grouped under this page 1 Disease areas Disease areas 19 Journals published in Journals published in 48 Financing and grant events Financing and grant events 1 Organization relationships Organization relationships 2 Latest dated events Latest dated events 27

Rows recorded per section (log scale)

18 sections measured, none recorded

This page covers Pharming Group N.V. and 1 company grouped under it: 22 lead-sponsored trials (0 its own, 22 in the grouped companies) and 4 legal-entity registrations (3 its own, 1 in the grouped companies).

Get the Pharming Group N.V. report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Companies grouped under this page (1)

Companies grouped under this page
Company Lead trials Legal entities
Pharming Technologies B.V. 22 1

Disease areas (19)

Shown in this order: most trials first.

Disease areas
Disease area Trials
Primary Immunodeficiency Diseases 10
Angioedema 9
Angioedemas, Hereditary 9
Acute Kidney Injury 2
Inflammation 2

Showing 5 of 19 disease areas.

Start your 14-day trial Email me all 19 disease areas as a PDF

Journals published in (48)

Shown in this order: most published in first.

Journals published in
Journal Publications
Transplantation 9
American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 7
Kidney international 4
Clinical transplantation 3
Journal of the American Society of Nephrology : JASN 3

Showing 5 of 48 journals.

Start your 14-day trial Email me all 48 journals as a PDF

Financing and grant events (1)

Financing and grant events
Date Round type Amount (USD) Source
2020-12-23 Other financing not disclosed Edgar offerings

Organization relationships (2)

Shown in this order: most evidence first.

Organization relationships
Related organization Relationship Evidence
Fortrea Holdings Inc. Uses vendor 2
Icon Plc Uses vendor 1

Latest dated events (27)

Shown in this order: newest first.

Latest dated events
Date Event Source
2026-06-12 Trial started Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI))
2025-04-29 Trial started Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI))
2025-02-12 Trial started Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI))
2024-10-21 Trial started Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI))
2023-08-30 Trial started Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI))

Showing 5 of 27 events.

Start your 14-day trial Email me all 27 events as a PDF

Not on this page

Checked, with nothing recorded for this organization: related companies not grouped here, trials by start year as sponsor or collaborator, active development programs, approved assets, sponsor delivery record, us granted patents, sec-reported annual financials, fda warning letters, fda untitled letters, fda inspection record, fda recalls, fda import refusals, manufacturing and distribution sites, climate targets, as filed, workforce and board diversity, as filed, clia clinical laboratory certificates, biomarker capability evidence, and biomarkers this organization publishes on.